In comparison, Dai et al
Am J Pathol 175 , 22572263
Based on these findings, we constructed a gut microbial marker map for the comorbidity of T2DM, AD, and PCOS (seen Figure 2), highlighting the consistent reduction of Bacteroides across all three conditions
Do you need to be a specific BMI to start microdosing
*Correspondence: Szymon Drygaa, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Advances in Glutathione Research for Disease Research Targeted therapy for GSH metabolism has become a research hotspot, and metabolomics and proteomics technologies have also provided powerful tools for GSH-related research: Targeting GSH metabolism : Inhibiting key molecules such as GCLC, xCT (cysteine uptake carrier) or SLC25A39 (mitochondrial GSH transporter), or using GSH-depleting nanozymes, has shown the potential to enhance ROS-mediated tumor cell death and improve related disease symptoms in preclinical models (such as cell models and animal models), providing new strategies for disease treatment
